SYMBIOTICS

Symbiotics is the leading market access platform for impact investing. Over the past decade, the company has originated and structured nearly 3600 investment transactions, worth more than USD 4.8 billion, on behalf of more than 420 companies in approximately 80 emerging and frontier markets, all serving a measurable sustainable and inclusive finance objective, purchased by 50 different investment funds and institutional investors. Symbiotics is a registered asset manager in Switzerland, a registered investment adviser in the United Kingdom, and has further office presence in Mexico, the Netherlands, Singapore and South Africa, regrouping more than 150 employees worldwide.

Through its new online platform Plumseeds.com, for professional investors seeking impact investments in emerging markets, Symbiotics believes in being transparent about the financial benefits, the social impact and the associated risks. That way, qualified investors can make an informed investment decision and build their own impact investment portfolio.

 

www.symbioticsgroup.com